TY  - JOUR
AU  - Lu, Qirong
AU  - Zhao, Yongxia
AU  - Xu, Xiaoqing
AU  - Guo, Pu
AU  - Ares Lombán, Irma
AU  - Martínez Caballero, Marta
AU  - López Torres, Bernardo
AU  - Martínez Larrañaga, María Rosa
AU  - Anadón Navarro, Arturo Ramón
AU  - Pan, Yuanhu
AU  - Wang, Xu
AU  - Martínez Caballero, María Aranzazu
PY  - 2025
DO  - 10.1016/j.bcp.2025.117420
SN  - 0006-2952
UR  - https://hdl.handle.net/20.500.14352/125071
T2  - Biochemical Pharmacology
AB  - Acute lung injury (ALI) is a multi-system and multifactorial disease, which is characterised by an uncontrolled inflammatory response and high mortality. Zaltoprofen (ZPF), is a non-steroidal anti-inflammatory drug (NSAID) with powerful...
LA  - eng
M2  - 1
PB  - Elsevier Inc.
KW  - Acute lung injury
KW  - Dual target
KW  - Cyclooxygenase-2
KW  - Peroxisome proliferator-activated receptor-γ
KW  - Zaltoprofen
KW  - Strategy
TI  - Zaltoprofen and its novel analogues exhibit dual targeting of COX-2 and PPAR-γ, providing a strategy to alleviate lipopolysaccharide – induced acute lung injury.
TY  - journal article
VL  - 242
ER  -